EVP R&D, Chief Medical Officer
Thu, Jan 8, 2026
Jan 8
5,000 shares @ $30.00
Decreased holdings by -7.50%
Net across this filing: 0.00% (+0 shares)
42nd largest trade (out of 157)
Planned (10b5-1)
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Net holdings across this filing: +0.0% (+0 shares)